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Hypoxia-inducible factors (HIFs) are critical regula-
tors of the cellular response to hypoxia. Despite
their established roles in normal physiology and
numerous pathologies, the molecular mechanisms
by which they control gene expression remain poorly
understood. We report here a conserved role for the
TIP60 complex as a HIF1 transcriptional cofactor in
Drosophila and human cells. TIP60 (KAT5) is required
for HIF1-dependent gene expression in fly cells and
embryos and colorectal cancer cells. HIF1A interacts
with and recruits TIP60 to chromatin. TIP60 is
dispensable for HIF1A association with its target
genes but is required for HIF1A-dependent chro-
matin modification and RNA polymerase II activation
in hypoxia. In human cells, global analysis of HIF1A-
dependent gene activity reveals that most HIF1A tar-
gets require either TIP60, the CDK8-Mediator com-
plex, or both as coactivators for full expression in
hypoxia. Thus, HIF1A employs functionally diverse
cofactors to regulate different subsets of genes
within its transcriptional program.
INTRODUCTION
The cellular response to hypoxia is essential for normal physio-
logical processes, such as embryonic development and stem
cell maintenance (Dunwoodie, 2009; Mazumdar et al., 2009),
but is also involved in diverse human pathologies, including
cancer, stroke, and heart failure (Majmundar et al., 2010; Se-
menza, 2012a). At the transcriptional level, the response to
hypoxia is largely governed by hypoxia-inducible factors
(HIFs) (Dengler et al., 2014; Semenza, 2009). In human cells,
numerous studies have delineated how the oxygen-sensitive
subunits HIF1A and HIF2A are stabilized and activated in hyp-
oxia and have identified hundreds of their target genes, but lessThis is an open access article under the CC BY-Nis known about the mechanisms employed by HIFs to stimulate
RNAPII activity.
It is generally accepted that the lysine (K) acetyl-transferases
(KATs) p300/CBP are key HIF transcriptional coactivators
(Arany et al., 1996; Ebert and Bunn, 1998; Ruas et al., 2002,
2005). However, abrogation of the interaction between HIF1A
and p300/CBP affects the expression of only a few HIF target
genes (Kasper et al., 2005). Here, we report the identification
of a conserved role for the TIP60 chromatin-modifying complex
as a HIF1A transcriptional cofactor. We show that HIF1A uti-
lizes TIP60 (KAT5) for full induction of specific target genes
and for histone acetylation and RNAPII activation upon hypoxia
at these loci. We find that HIF1A physically associates with
components of the TIP60 complex and is required for TIP60
recruitment to chromatin. Global analyses of gene expression
in human cells depleted of HIF1A, TIP60, or CDK8 revealed
that, across much of its transcriptional program, HIF1A em-
ploys TIP60, CDK8-Mediator, or both as gene-specific coacti-
vators. Altogether, our results illuminate the orchestrated action
of functionally diverse cofactors during the transcriptional
response to hypoxia.
RESULTS
Components of the TIP60 Complex Modulate HIF Target
Gene Activation in Drosophila
We previously carried out a genome-wide screen in Drosophila
S2 cells and identified Pontin and Reptin as two of the strongest
regulators of HIF-dependent transcription using a HIF reporter
system (Dekanty et al., 2010). Pontin (RUVBL1 and TIP49) and
Reptin (RUVBL2 and TIP48) are AAA+ ATPases with diverse
cellular functions, including transcriptional regulation (Gallant,
2007). Here, we analyzed their requirement in vivo using
Drosophila transgenic lines bearing a HIF-dependent LacZ re-
porter (Lavista-Llanos et al., 2002) and null mutations at the pon-
tin (pont) or reptin (rept) loci. Whereas the reporter is highly
induced in wild-type Drosophila embryos subjected to hypoxia
(5% O2 4 hr), its activity is severely compromised in pontin and
reptin mutants (Figure 1A).Cell Reports 16, 37–47, June 28, 2016 ª 2016 The Authors. 37
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A B
D
Hypoxia inducible genes (1185)
HIF1A-dependent genes (590)
TIP60-dependent genes (145)
log2 fold change
−8 −6 −4 −2 0 2 4 6 8
0
20
40
60
80
100
120
140
-lo
g 1
0(
p-
va
lu
e)
1185 genes induced
by hypoxia
11
85
 g
en
es
 in
du
ce
d 
by
 h
yp
ox
ia
HI
F1
A -
/-
sh
NT
sh
TIP
60
7.2 1.6 -0.6 -5.4
log2 fold-change 
C
HREs CRE LacZ
Drosophila embryos
21% O2 5% O2
5% O2
wild-type
wild-type wild-type
wild-type
reptin -
pontin -
Drosophila S2 cells: normoxia hypoxia
R
el
at
iv
e 
m
R
N
A
 E
xp
re
ss
io
n
dsRNA: cont
rol Sim
a 
Tan
go 
Pon
tin Rep
tin 
Tip6
0 
Dom
ino Ino8
0 
Ldh
0 
2 
4 
6 
8 
10 
12 
14 
*
*
* *
*
*
Hsf
0.0 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
*
*
*
** *
FgaB
0 
2 
4 
6 
8 
10 
* * *
* *
*
*
*
*
HCT116 cells: normoxia hypoxia
shRNA:
0.0 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
4.5 
**
NR4A1
NT #1 #2 #3
shTIP60
0 
1 
2 
3 
4 
5 
6 
***
DUSP1
NT #1 #2 #3
shTIP60
0 
1 
2 
3 
4 
5 
6 
7 
8 
*
*
*
PER1
NT #1 #2 #3
shTIP60
R
el
at
iv
e 
m
R
N
A
E
xp
re
ss
io
n 
0 
20 
40 
60 
80 
100 
120 
140 
160 
*
*
*
*
*
ANKRD37
NT #1 #2 #3
shTIP60
HIF1A-dependent (590)
TIP60-dependent (145)
ANKRD37
SLC2A3
ANGPTL4
NR4A1
(legend on next page)
38 Cell Reports 16, 37–47, June 28, 2016
Pontin and Reptin are components of multiple complexes with
roles in transcription, including the TIP60 and INO80 complexes
(Jha et al., 2013; Jo´nsson et al., 2004; Sapountzi et al., 2006). To
determine whether these complexes are involved in HIF-depen-
dent transcription, we tested the effect of depleting shared and
specific subunits on expression of known HIF targets in S2 cells
under normoxia and hypoxia (Hsf, FgaB (Hph-RA), and Ldh
(ImpL3); Figures 1B and S1A). Depletion of Pontin, Reptin, or
two different subunits specific to the TIP60 complex, Tip60
(KAT5) and Domino (p400), impaired the induction of two of three
genes tested (Figure 1B). In contrast, depletion of Ino80 had a
lesser effect. Depletion of the Drosophila homologs of HIF1A
(Sima) and HIF1B/ARNT (Tango) confirmed HIF1-dependent in-
duction of these genes. Together, these results suggest a role
for the Pontin- and Reptin-containing Drosophila Tip60 complex
as a gene-specific HIF transcriptional coactivator.
TIP60 Depletion Impairs Expression of Specific HIF1A
Target Genes in Human Cells
We next asked whether this role of the TIP60 complex is
conserved in human cells. We first depleted the catalytic subunit
KAT5 using three independent short hairpin RNAs (shRNAs) in
HCT116 colorectal carcinoma cells (shTIP60) and confirmed
that TIP60 knockdown did not affect HIF1A stabilization in
hypoxia (1% O2 24 hr; Figures S1B and S1C). Examination of
the effect on expression of a panel of HIF1A-dependent
genes revealed gene-specific TIP60 requirements (Figures 1C
and S1D–S1F). For example, whereas induced expression of
ANKRD37 and NR4A1 is reduced by >50% (Figure 1C), expres-
sion of ALDOA and JMJD1A remains unaffected (Figure S1F). A
similar gene-specific requirement for TIP60 was also observed in
a different colon-cancer-derived cell type, SW480 (Figure S1G).
To define the contribution of TIP60 to the global HIF1A-driven
transcriptional response, we used RNA-seq to measure mRNA
levels in HIF1A/ and shTIP60 HCT116 cells under normoxic
and hypoxic conditions. From 14,000 expressed genes, our
analysis identified 1,185 genes significantly induced by hypoxia,
of which half (590; 49.7%) showed significantly reduced expres-
sion during hypoxia in HIF1A/ cells (Figure 1D; Table S1). In
turn, 25% (145) of these HIF1A-dependent genes relied on
TIP60 for full expression during hypoxia, demonstrating thatFigure 1. Subunits of the TIP60 Complex Modulate HIF Target Gene Ex
(A) Schematic diagram of the murine Ldha enhancer-derived hypoxia-response el
response element. Wild-type and pontin or reptin mutant embryos subjected
reporter activity.
(B) RelativemRNA levels for HIF target genes, as assessed by qRT-PCR, inDrosop
or hypoxia (1% O2 20 hr). Expression values were normalized to Rpl29 RNA and
mean ± SEM from at least three independent replicates. Asterisks indicate p val
(C) RelativemRNA levels for HIF1 target genes, as assessed by qRT-PCR, for HCT
or hypoxia (1% O2 24 hr). Expression values were normalized to 18S rRNA and
mean ± SEM from at least three independent replicates. Asterisks indicate p val
(D) RNA-seq analysis of global mRNA levels in shNT control, HIF1A/, and shTI
against log10 p value for all genes in normoxia versus hypoxia is shown. Gree
dependent genes that are also TIP60 dependent. Selected genes of interest are in
change values is shown. Right: Venn diagram representing the genes induced by
(purple) for hypoxic induction is shown. In all cases, hypoxic induction is defined a
p value < 10% and requirement for HIF1A or TIP60 is defined as ratio (HIF1A/
See also Figure S1.TIP60 makes a substantial contribution to the HIF1A-driven
expression program.
TIP60 Complex Subunits Are Recruited to HIF1A Target
Genes
To explore the mechanistic basis for TIP60 requirement in
HIF1A-driven gene expression, we performed quantitative chro-
matin immunoprecipitation (ChIP) analysis of the ANKRD37 lo-
cus, a hypoxia-responsive gene strongly affected by TIP60
depletion. Analysis of HIF1A binding to the ANKRD37 locus
demonstrated that TIP60 knockdown does not alter HIF1A asso-
ciation with chromatin upon hypoxia (Figure 2A).
We next asked whether the TIP60 complex localizes to this
gene by assessing occupancy of TIP60, Reptin, and TRRAP (Fig-
ures 2B–2D). All three subunits were found to associate with the
ANKRD37 promoter, with their occupancy peaking in hypoxia.
Interestingly, Reptin and TRRAP exhibit relatively strong enrich-
ment even in normoxic conditions. This could be explained by
their reported roles within other chromatin-associated com-
plexes distinct from the TIP60 complex or by basal but undetect-
able recruitment of TIP60 itself in normoxia (see next section).
Note that TIP60 depletion modestly affects occupancy of both
Reptin and TRRAP (Figures 2C and 2D), and TIP60 enrichment
is expectedly low in TIP60-depleted cells (Figure 2B).
TIP60 Depletion Compromises HIF1A-Dependent
RNAPII Activation and Histone Acetylation
Many HIF1A target genes, including ANKRD37, exhibit pro-
moter-proximal paused RNAPII during normoxia, and their acti-
vation under hypoxia requires conversion of paused RNAPII into
an elongation-competent form (Galbraith et al., 2013). This pro-
cess typically involves phosphorylation of the C-terminal domain
(CTD) of RNAPII. Therefore, we tested the influence of TIP60 on
total and phosphorylated RNAPII. Expectedly, hypoxia provokes
an increase in total RNAPII levels throughout the body of the
ANKRD37 gene with a peak near the transcription start site (Fig-
ure 2E) and stimulates RNAPII activation, as indicated by CTD
serine 5 phosphorylation (S5P) (Figure 2F). Whereas TIP60
depletion has a small effect on normoxic levels, it causes a sub-
stantial reduction in induced enrichment of both total and
S5P-RNAPII across the ANKRD37 locus. This suggests thatpression in Drosophila and Human Cells
ement (HRE)-LacZ reporter construct inserted into the fly genome. CRE, cAMP
to normoxia or hypoxia (5% O2 4 hr) were stained with X-gal (blue) to visualize
hilaS2 cells treatedwith the indicated dsRNAs andmaintained under normoxia
are expressed relative to the control normoxia value. Data are represented as
ues% 0.05 by one-way ANOVA.
116 cells stably expressing shRNAs targeting TIP60 and subjected to normoxia
are expressed relative to the control normoxia value. Data are represented as
ues% 0.05 by one-way ANOVA.
P60 HCT116 cells subjected to hypoxia. Left: volcano plot of log2 fold change
n circles, HIF1A-dependent hypoxia-inducible genes; purple circles, HIF1A-
dicated by red arrows, with labels on right. Middle: heatmap of mRNA log2 fold
hypoxia (gray) and subsets that require HIF1A (green) or both HIF1A and TIP60
s ratio (shNT normoxia/shNT hypoxia)R 2, false discovery rate (FDR)-adjusted
or shTIP60 hypoxia/shNT hypoxia)% 0.9, FDR-adjusted p value < 10%.
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Figure 2. TIP60 Is Required for RNAPII Acti-
vation and Histone Acetylation at the
ANKRD37 Locus
Quantitative ChIP analysis of (A) HIF1A, (B) TIP60,
(C) Reptin, (D) TRRAP, (E) total RNAPII, (F) serine-
5-phosphorylated RNAPII CTD (S5P), and (G and
H) histone acetylation (H3K9ac and pan-H4ac) at
the ANKRD37 locus in control and shTIP60
HCT116 cells in normoxia or hypoxia (1% O2
24 hr). To represent profiles across the locus,
values are plotted as percentage of maximum
signal for each epitope. Data are represented as
mean ± SEM from three independent replicates.
Gray area indicates the transcribed region.TIP60 is a direct positive regulator of RNAPII activity at HIF1A-
responsive genes.
Because histone acetylation is associated with HIF1A-depen-
dent gene activation (Johnson et al., 2008) and the TIP60 com-
plex has well-established KAT activity, we next asked whether
this complex promotes HIF1A-dependent histone acetylation.
We found that TIP60 depletion diminishes acetylation of
histone H3 lysine 9 (H3K9) and histone H4 (Figures 2G and
2H), two acetylation events previously shown to depend on
HIF1A (Galbraith et al., 2013). Although TIP60 recruitment is
maximal during hypoxia, its depletion also impairs histone acet-
ylation during normoxia. This might reflect a low basal recruit-
ment of the TIP60 complex, which is consistent with levels of
HIF1A, Reptin, and TRRAP observed during normoxia at the
ANKRD37 locus (Figures 2A, 2C, and 2D). Notably, ANKRD37
is one of a minority of HIF1A-dependent genes whose normoxic
expression is affected by depletion of TIP60. Overall, these re-
sults demonstrate that TIP60 is required for maximal HIF1A-
dependent RNAPII activation and histone hyper-acetylation at
the ANKRD37 locus.
HIF1A Directs the TIP60 Complex to Chromatin
We next asked whether HIF1A is required for recruitment of the
TIP60 complex to chromatin. Using ChIP in isogenic wild-type
and HIF1A/ HCT116 cells, we found that maximal occupancy
of the ANKRD37 locus by the TIP60, Reptin, and TRRAP sub-40 Cell Reports 16, 37–47, June 28, 2016units of the TIP60 complex under hypoxia
requires HIF1A (Figure 3A).
To test whether HIF1A associates
physically with the TIP60 complex, we
performed HaloTag (HT) pull-down and
mass spectrometry analysis of HIF1A-in-
teracting proteins from HEK293T cells
expressing Halo-tagged-HIF1A or control
HT alone and treated with desferriox-
amine (DFX) to induceHIF1A stabilization.
Using this approach, in addition to known
HIF1A interactors, such as HIF1B (ARNT)
and VHL, we detected Reptin and Pontin
(Figures 3B and S2A; Table S2). Detection
of an interaction with VHL, a subunit of the
E3 ligase complex that targets HIF1A for
degradation when hydroxylated at keyresidues during normoxia, suggests that, in this context, some
HT-HIF1A remains hydroxylated, despite treatment with DFX.
Also present, albeit at lower abundance, were three other poten-
tial TIP60 complex subunits, TRRAP, BAF53A (ACTL6a), and
p400 (EP400), as well as p300 (EP300).
We next tested for physical proximity between HIF1A and
TIP60 complex subunits in live cells using a nano-luciferase
bioluminescent resonance energy transfer (NanoBRET) assay
(Machleidt et al., 2015) in HCT116 and HEK293 cells (Figures
3C and S2B). In agreement with our mass spectrometry analysis,
we detected energy transfer from HIF1A-NanoLuc (HIF1A-NL) to
HT-Pontin and HT-Reptin. These interaction signals were not
significantly enhanced by DFX treatment, which could be ex-
plained by the fact that ectopic expression of HIF1A-NL by-
passes the need for hypoxia-induced stabilization. Notably, we
detected a stronger signal for HT-TIP60 than for HT-Pontin and
HT-Reptin. This suggests that, despite not being detected by
mass spectrometry, TIP60 can also interact with HIF1A in cells.
This could be explained by poor performance or low relative
abundance of TIP60-derived peptides in the mass spectrometry
assay. Of note, nanoBRET ratios are influenced bymany factors,
including close proximity, relative affinity, occupancy, and
expression level, and therefore, higher values do not necessarily
indicate a higher affinity interaction. Importantly, all signals were
greater than for the HT control (Figure S2C). To confirm the
HIF1A-TIP60 interaction, we performed HT pull-down from
HCT116 cells co-expressing HT-TIP60, HT-Pontin, HT-Reptin,
or HT control with HIF1A-NL (Figures 3D and S2D). After isola-
tion, complexes were assayed for luciferase activity as a mea-
sure of interaction with HIF1A-NL. We observed an enrichment
in luciferase signal, over the HT control, for all three pull-downs,
with HT-TIP60 again displaying the strongest signal (Figure 3D).
Treatment with DFX induced a small, albeit not statistically signif-
icant, increase in signal. The interaction between HT-TIP60 and
HIF1A-NL was also observed in HEK293 cells (Figure S3D).
Taken together, our data suggest that HIF1A can physically
interact with components of the TIP60 complex and direct their
recruitment to chromatin during hypoxia.
HIF1A Employs TIP60 and CDK8-Mediator as
Coactivators across Much of Its Transcriptional
Program
We recently discovered that HIF1A employs the CDK8-Mediator
complex as a coactivator at many of its target genes (Galbraith
et al., 2013). To define the relative contributions of both TIP60
and CDK8 to the transcriptional response during hypoxia, we
compared RNA-seq data for HCT116 cells depleted of CDK8
(shCDK8) to our previous data for HIF1A/ and shTIP60
HCT116 cells (Figure 4A; Table S1). This analysis revealed that
TIP60 and CDK8 affect distinct but overlapping sets of genes
and, collectively, contribute to the induced expression of
>60% (363 out of 590) of genes across the HIF1A network. We
defined four classes of HIF1A-dependent genes. Class I genes
require HIF1A, but not TIP60 or CDK8, for full expression. Class
II genes require HIF1A and CDK8, but not TIP60. Class III genes
require HIF1A, CDK8, and TIP60. Class IV genes require HIF1A
and TIP60, but not CDK8. Each class contains known HIF1A
target genes displaying differential requirement for CDK8 and
TIP60 (Figure 4B). The differential requirement for TIP60 across
select genes in classes I, III, and IV (PDK1, FAT4, and EMP1)
was confirmed by qRT-PCR (Figure S3A). Next, we examined
markers of transcriptional activity at these loci upon TIP60
knockdown (Figure S3B). Depletion of TIP60 largely abrogated
enrichment of total and phosphorylated RNAPII at FAT4 (class
III) and EMP1 (class IV), but not PDK1 (class I). Interestingly,
TIP60 depletion also affected histone H4 acetylation at PDK1,
a TIP60-independent gene, suggesting that TIP60 may be re-
cruited and active even at loci where it is not required for
RNAPII activity or full mRNA induction. We also confirmed that
these genes are likely direct HIF1A target genes, as HIF1A deple-
tion led to reduced levels of total and phosphorylated RNAPII,
TIP60 recruitment, and histone acetylation (Figure S3C). We
also analyzed a hypoxia-inducible gene that does not require
HIF1A, TIP60, or CDK8 (CYR61; Figures S3A–S3C). TIP60 and
HIF1A depletion did not affect total RNAPII at this locus (Figures
S3B and S3C). However, their depletion did impact Ser5 phos-
phorylation, and as observed for the class I gene PDK1, TIP60
knockdown reduced histone acetylation at CYR61 despite not
being necessary for CYR61 mRNA expression. HIF1A depletion
had minor effects on TIP60 and histone acetylation at this locus
(Figure S3C). Altogether, these results indicate that TIP60 is re-
cruited to many classes of hypoxia-inducible genes, where it
contributes to histone acetylation, yet it is only required for
RNAPII activity and mRNA production at classes III and IV.Note that the requirement for TIP60 is not simply defined by its
chromatin occupancy and that its ultimate effects on RNAPII at
a given locus are likely defined by other, unknown variables
(see below). Furthermore, because our ChIP analyses may not
have captured the site of maximum TIP60 occupancy at each lo-
cus, a quantitative relationship between TIP60 association and
its impact on RNAPII activity cannot be established. Because
histone H4 acetylation is affected by TIP60 knockdown at all
genes analyzed, TIP60 effects could be driven by other acetyla-
tion targets in the transcriptional apparatus. In fact, several non-
histone TIP60 targets, including transcription factors, have been
identified (Patel et al., 2004; Sun et al., 2005; Tang et al., 2006,
2008; Xiao et al., 2014).
Of note, the differential requirements for TIP60 and CDK8
across the HIF1A-driven gene expression program are not sim-
ply a consequence of a general effect on transcription, as their
overall contributions to global mRNA levels in normoxic cells
are much smaller, with TIP60 affecting many more genes
than CDK8 (Figure S4A). These results suggest that alternative
coactivator usage by HIF1A could confer regulatory flexibility to
the transcriptional response to hypoxia. Moreover, the differen-
tial coactivator requirements of subsets of genes might depend
in part on the ability of HIF1A to cooperate with other transcrip-
tion factors (Dang et al., 2008; Gray et al., 2005; Xia and Kung,
2009). To search for factors with potential to differentially regu-
late subsets of HIF1A target genes, we identified known up-
stream transcriptional regulators of each gene class in our
RNA-seq dataset using Ingenuity Pathway Analysis (IPA) (Fig-
ure S4B). Expectedly, HIF1A was the top prediction for all
HIF1-dependent hypoxia-inducible genes, as well as for the
four classes within this group, but not for HIF1A-independent
genes. HIF2A is the second inferred regulator for HIF1A-depen-
dent genes as well as a top prediction for gene classes I and II,
which likely reflects its many shared target genes with HIF1A.
When comparing the top ten enriched regulators across each
of the four gene classes, we identified transcription factors
that are predicted to regulate genes within specific classes
(Figure S4C). For example, whereas SP3 may regulate only
genes in class I, STAT6 could regulate genes in classes II
and III, both of which require CDK8 for full expression. Thus,
we propose that the combinatorial action of HIF1A with other
transcription factors may enable the fine-tuning of the tran-
scriptional response to hypoxia to favor diverse biological re-
sponses in a context-dependent fashion. Indeed, analysis of
the different gene classes identified here also revealed distinct
functional pathways controlled by this putative mechanism
(Figure S4D).
Finally, to examine the roles of TIP60 and CDK8 in oncogenic
properties of colorectal cancer cells, we measured the ability of
non-targeting shRNA (shNT) control, shTIP60, shCDK8, and
HIF1A/ HCT116 cells to initiate and sustain growth of three-
dimensional colonies in soft agar, which quickly reach a size
large enough to create hypoxic conditions at their core (Indovina
et al., 2007; Lin et al., 2012; Meng et al., 2012; Sutherland et al.,
1986). These assays are considered a good surrogate of the ‘‘tu-
mor-initiating ability’’ of cancer cells (i.e., ‘‘stemness’’) and their
ability to adapt to hypoxic conditions. Importantly, this assay is
exquisitely sensitive to HIF1A activity in multiple cell typesCell Reports 16, 37–47, June 28, 2016 41
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Figure 3. HIF1A Directs the TIP60 Complex to Chromatin
(A) Quantitative ChIP analysis of TIP60, TRRAP, and Reptin at the ANKRD37 locus in wild-type and HIF1A/HCT116 cells in normoxia or hypoxia (1%O2 24 hr).
To represent profiles across the locus, values are plotted as percentage of maximum signal for each epitope. Data are represented as mean ± SEM from three
independent replicates. Gray area indicates the transcribed region.
(B) Identification of HaloTag (HT)-HIF1A interactors by pull-down and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Average
normalized spectral abundance factors (NSAFs) from two biological replicates are shown for selected proteins isolated in complex with HT-HIF1A from des-
ferrioxamine (DFX)-treated HEK293T cells. Known HIF1A interactors are shown in blue, and subunits of the TIP60 complex are shown in red.
(C) NanoBRET assaysmeasuring proximity of HIF1A to TIP60, Pontin, and Reptin. HCT116 cells were co-transfected with HIF1A-NL (donor) and either HT-TIP60,
HT-Pontin, or HT-Reptin (acceptors). Graph shows corrected milliBRET units for each acceptor fusion protein when combined with the HIF1A-NL donor. Higher
(legend continued on next page)
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(Dang et al., 2006; Leek et al., 2005; Onnis et al., 2013; Rohwer
et al., 2008), including when incubated at 21% oxygen (Dang
et al., 2006). Whereas HCT116 HIF1A/ cells do not show sig-
nificant proliferation defects in monolayers, they completely fail
to form colonies in soft agar (Figures 4C and 4D). Therefore,
this assay provides a great opportunity to gauge the contribution
of TIP60 and CDK8 to a cellular process that is fully dependent
on HIF1A. Hypoxia is known to stimulate ‘‘stemness’’ and clono-
genicity, along with induction of HIF1A target genes (Lee and
Simon, 2012; Yeung et al., 2011). We therefore performed the
assay under conditions of normoxia and hypoxia. In wild-type
HCT116 cells, introducing hypoxia from the time of seeding stim-
ulates colony formation efficiency, as seen by increased colony
numbers, although without reaching statistical significance (Fig-
ures 4C and 4D). The stimulatory effect of hypoxia is completely
lost in HIF1A/ cells, consistent with the ability of HIF1A to
promote stemness in colon cancer cells (Yeung et al., 2011).
However, the stimulatory effect of hypoxia can be observed, to
varying degrees, in TIP60- and CDK8-depleted cells, which
can be explained by the fact that these cells retain the ability to
induce a fraction of the HIF1A-dependent transcriptional pro-
gram (Figure 4A). In fact, the amount of colonies formed under
hypoxia inversely correlates with the contributions of HIF1A,
TIP60, and CDK8 to the hypoxia-inducible program. Altogether,
these data suggest that HIF1A, TIP60, and CDK8 may promote
tumorigenesis through their contributions to a common tran-
scriptional program.
DISCUSSION
The cellular response to hypoxia is important in normal physi-
ology and disease (Semenza, 2012a). In particular, hypoxia
favors tumor progression by promoting angiogenesis, epithe-
lial-to-mesenchymal transition, and metabolic reprogramming
(Mucaj et al., 2012; Semenza, 2012b). It is therefore imperative
to understand the molecular basis by which cells respond to
this stress. The transcription factors HIF1A and HIF2A are the
key factors governing the transcriptional response to hypoxia,
yet the mechanisms by which they regulate RNAPII have yet to
be fully elucidated (Dengler et al., 2014). Here, we identified a
conserved role for the TIP60 complex in HIF1A-dependent trans-
activation and investigated differential requirements for TIP60
andCDK8 as coactivators in the regulation of HIF1A target genes
in human cancer cells.
Repeatedly, the related KATs p300 and CBP have been re-
ported as key HIF1A coactivators (Arany et al., 1996; Cho
et al., 2007; Ebert and Bunn, 1998; Ema et al., 1999; Kallio
et al., 1998; Ruas et al., 2010). However, mutation of their CH1
domains to disrupt HIF interaction was shown to affect expres-
sion of only a small number of HIF target genes (Kasper et al.,
2005). Our data show that a different KAT, TIP60, contributesvalues indicate closer proximity. Data are represented as mean + SEM from three
values gave p values < 0.05 by t test.
(D) HT pull-down from HCT116 cells co-expressing HT-TIP60, HT-Pontin, HT-R
ciation with HT-TIP60, or HT control, was measured by detection of luciferase a
replicates. None of the comparisons between untreated and DFX values gave p
See also Figure S2.to the induction of specific HIF1A targets and suggest that it
may be a common driver of HIF1A-driven histone acetylation.
We found that TIP60 is required for HIF1-dependent gene
expression in Drosophila and two different human cancer cell
lines, HIF1A interacts with and recruits TIP60 to chromatin, and
TIP60 is dispensable for HIF1A association with its target genes
but is required for HIF1A-dependent chromatin modification and
RNAPII activation in hypoxia.
It has been suggested that Pontin and Reptin play opposite
roles in HIF1-dependent transcription (Lee et al., 2010, 2011).
However, we found here that both Pontin andReptin are required
for HIF1 transcriptional activity in Drosophila cultured cells and
embryos (Figures 1A and 1B). This contrasting requirement
could be explained by locus-specific functions and the critical
role of Pontin and Reptin in assembly of the TIP60 complex
and its acetyl-transferase activity (Jha et al., 2013). In agreement
with this notion, we found that depletion of the Tip60 or Domino
(p400) subunits reproduced the gene-specific effects of Pontin
and Reptin depletion in S2 cells (Figure 1B). Thus, we focused
our investigation on the defining subunit of the complex, TIP60
(KAT5).
Recently, we demonstrated that a specific variant of the Medi-
ator complex plays a widespread role in HIF1A coactivation (Gal-
braith et al., 2013). Our transcriptome analysis shows that HIF1A
employs TIP60, CDK8-Mediator, or both as coactivators across
much of its transcriptional program. Together, these two coacti-
vators contribute to induced expression of >60% of HIF1A-
driven genes. It would be interesting to determine in our system
what fraction of HIF1A targets requires other known coactiva-
tors, such as PKM2 (Luo et al., 2011).
Why do different HIF1A target genes display differential re-
quirement for TIP60, CDK8, or other coactivators? Using publicly
available ENCODE data for the HCT116 cell line, we looked for
differences in regulatory chromatin modifications but did not
find any striking differences between our gene classes that might
explain differential cofactor requirement. Another possibility is
that coactivator requirement is defined by the combinatorial ac-
tion of HIF1A and its partner transcription factors (Dang et al.,
2008; Gray et al., 2005; Xia and Kung, 2009). Our bioinformatics
analysis supports this notion by predicting multiple transcription
factors in addition to HIF1A as upstream regulators of our various
gene classes (Figures S4B and S4C). Mechanistically, the coor-
dinated binding of HIF1A and a specific partner transcription fac-
tor may allow recruitment of different coactivators that are
required at specific genes. In turn, this layered action of partner
transcription factors and coactivators may provide flexibility to
the HIF1A-driven transcriptional program, veering it toward
different cellular outcomes in a context-dependent manner.
Furthermore, we observed enrichment of different cellular path-
ways between our gene classes (Figure S4D), and it would there-
fore be interesting to examine the role of HIF1A coactivators andindependent replicates. None of the comparisons between untreated and DFX
eptin, or HT control with HIF1A-NL. Pull-down of HIF1A-NL by physical asso-
ctivity. Data are represented as mean + SEM from at least three independent
values < 0.05 by t test.
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Figure 4. TIP60 and CDK8 Are Required for Expression of Specific Subsets of HIF1A Target Genes
Differential coactivator requirement as determined by RNA-seq analysis (includes datasets used in Figure 1).
(A) Comparison of mRNA levels for hypoxia-inducible genes in shNT control, HIF1A/, shTIP60, and shCDK8 HCT116 cells in normoxia and hypoxia (1% O2
24 hr). HIF1A-dependent hypoxia-inducible genes were divided into four non-overlapping classes based on their coactivator dependency: CDK8- and TIP60
independent (class I); CDK8 dependent (class II); TIP60 dependent (class IV); and dependent on both TIP60 and CDK8 (class III). Hypoxia-inducible genes were
defined as ratio (shNT normoxia/shNT hypoxia)R 2, FDR-adjusted p value < 10%; cofactor requirement was defined as ratio% 0.9, FDR-adjusted p value < 10%
for HIF1A/, shTIP60, or shCDK8 over shNT cells in hypoxia. Heatmap shows mRNA levels as RPKM (reads per kilobase per million) for all HIF1A-dependent
hypoxia-inducible genes, normalized to the maximum signal for that gene.
(B) Left: Venn diagram showing the relative size of each class. Right: bubble plots showing relative mRNA levels for example known direct HIF1A target genes
within each class are shown. Surface area corresponds to RPKM values relative to shNT control cells in hypoxia.
(C and D) Anchorage-independent growth assay showing the ability of shNT control versus shTIP60, shCDK8, or HIF1A/ HCT116 cells to form colonies in soft
agar. Data are represented as mean + SEM. Asterisks indicate p values% 0.05 by t test against shNT in normoxia or hypoxia.
See also Figures S3 and S4.
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putative partner transcription factors (TFs) in regulation of these
pathways and phenotypic outcomes during hypoxia.
Many cancer cells experience hypoxia due to uncontrolled
proliferation and aberrant blood supply within tumors. In
hypoxic cancer cells, HIFs regulate genes involved in metabolic
reprograming, angiogenesis, stemness, epithelial-to-mesen-
chymal transition, invasion, metastasis, apoptosis, and resis-
tance to radiation and chemotherapy (Dengler et al., 2014; Se-
menza, 2012b). Accordingly, hypoxic tumors expressing high
levels of HIFs are known to be more aggressive and resistant
to various therapies. Our data here suggest that TIP60 and
CDK8, by regulating a fraction of the HIF1A transcription pro-
gram, may contribute to survival and proliferation of cancer cells
during hypoxia. Because both TIP60 and CDK8 are potentially
amenable to pharmacological inhibition (Cee et al., 2009; Ghiz-
zoni et al., 2012), it is possible to envision strategies for therapeu-
tic remodeling of the hypoxic response by selectively blocking
the activity of these HIF1A coactivators.
Altogether, the results presented here demonstrate a con-
served role for the TIP60 complex in the transcriptional response
to hypoxia, alone or in combination with CDK8-Mediator, at
HIF1A target genes. This paves the road for future studies
aimed at defining the mechanistic basis and biological implica-
tions of this functional relationship between three well-recog-
nized players in gene expression control.
EXPERIMENTAL PROCEDURES
Fly Stocks and b-Galactosidase Assay
Flies were yw; yw, LDH-LacZ (Lavista-Llanos et al., 2002). Pont5.1/TM3 (pon-
tin-) and rept35/TM3 (reptin-) flies were generously provided by Dr. Peter
Gallant (Julius Maximilians University of W€urzburg). To measure b-galactosi-
dase activity of the hypoxia-responsive reporter, embryos were exposed to
21% or 5% O2 for 4 hr. Embryos were then bleach-dechorionated, fixed
with 0.5% glutaraldehyde, washed with PBS + 1% Triton, and incubated
with a solution of X-gal.
Drosophila S2 Cell Culture, dsRNA Synthesis, and RNAi
Drosophila S2 cells were maintained at 25C in Schneider medium (Sigma),
supplemented with 10% fetal bovine serum (GIBCO), 50 mg/ml streptomycin,
and 50 units/ml penicillin. Double-stranded RNAs (dsRNAs) were synthe-
sized from cDNA with the T7 Megascript kit (Ambion). See Table S3 for
dsRNA sequences. Transfection of S2 cells with dsRNAs was performed in
24-well plates (Greiner) using the ‘‘bathing’’ method as previously described
(Clemens et al., 2000). After 4 days, cells were exposed to 1% O2 or kept in
normoxia for 20 hr. RNAwas extracted using Trizol (Life Technologies), cDNA
synthesized using the SuperScript III First-Strand Synthesis System (Life
Technologies), and gene expression analyzed by real-time PCR in a Strata-
geneMx3005P system (Agilent Technologies). Gene expression was normal-
ized to RPL29 levels.
Mammalian Cell Culture and Stable shRNA Knockdown Cell Lines
Cells were cultured in McCoy’s 5A (GIBCO/Life Technologies) or DMEM me-
dium (Sigma) supplemented with 10% fetal bovine serum and antibiotic-anti-
mycotic mixture (GIBCO/Life Technologies) under 5% CO2 at 37
C. HCT116
HIF1A/ cells were created by disrupting exons 3 and 4 of the HIF1A locus
using adeno-associated virus-mediated homologous recombination, resulting
in a 226-bp deletion with translation stop codons in all three reading frames
(Dang et al., 2006). Cells were plated 24 hr prior to experimental treatments
and harvested in radioimmunoprecipitation assay (RIPA) lysis buffer for protein
or Trizol for total RNA. Hypoxia treatments were carried out in incubation
chambers (Billups-Rothenberg) by flushing twice with 120 l of a mixture of
1% O2/5% CO2/94% N2 (Airgas) and incubated for 24 hr at 37
C. Individualknockdown cell lines were generated using Sigma Mission shRNA lentiviral
plasmids (pLKO.1-puro), as described previously (Galbraith et al., 2013). See
Table S3 for shRNA sequences.
RNA-Seq Analysis, ChIP, HT Pull-Down, and NanoBRET Assay
See Supplemental Experimental Procedures.
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